Integrated BioPharma Inc (INBP)

[Zunobira]

INBP will skyrocket ..Q3 around the corner

INBP was in nasdaq and got delisted in 2009, was traded at $3 to $4 range. All the past distress now gone, this stock will rise dramatically from this level. Key points are:

1. 6 months ended Dec 2011 (Q1+Q2 fiscal 2012), revenue rose 26% with operating profit $1.2M
2. Operating expenses were decreased significantly
3. Default is going to be handled by selling one subsidiary
4. Remaining subsidiaries will continue to deliver decent growth
5. Only 21M shares, 8M float.
6. Q3 ending March 2012 will be out in two weeks.
7. Fiscal 2012, ending June 2012 could post $40M+ revenue and a nice operating profit, and possibly a bottom line profit.
8. Market cap too low.
9. Check INBP's competitors NAII trading $7/sh, NUTR trading $15/sh
Net Effect: Move Up Up Up....